
The founder of the blood-testing start-up Theranos was sentenced to 11 years in prison for fraud and had been serving time at a minimum-security federal prison in Texas.
Elizabeth Holmes may be leaving prison early.
Ms. Holmes, the founder of the blood-testing start-up Theranos, who was convicted of fraud in 2022 and sentenced to 11 years behind bars
Ms. Holmes, 42, is expected to transfer from F.P.C. Bryan, a minimum-security federal prison camp for women roughly 90 minutes northwest of Houston where she began her sentence in May 2023. She will move to the Austin Transitional Center in Del Valle, Texas, on Aug. 23, 2027, according to the letter.
ABC News reported earlier on the letters to Ms. Holmes’s victims.
The move is a result of the First Step Act, a federal prison reform law signed in 2018 that allows prisoners with a low risk of recidivism to move early to community supervision, a person with knowledge of the situation said.
It is unclear how long Ms. Holmes may stay at the halfway house. The letter indicated that her scheduled release date was Feb. 22, 2030, though most prisoners stay in halfway houses for only a short time. Ms. Holmes’s sentence was already shortened several times. Last year, she filed a request to have her sentence commuted by the Department of Justice.
A representative from the Federal Bureau of Prisons said it did not discuss the conditions of confinement for any individual to protect prisoner privacy, safety and security.
Ms. Holmes has been back in the spotlight in recent weeks with the upcoming release of a documentary directed by Nathan Fielder, a comedian, and the filmmaker Lance Oppenheim, called “You Can See Everything.”
Mr. Fielder spent time with Ms. Holmes and her partner, the tech worker Billy Evans, in the weeks before she reported to prison, keeping the project a secret until recently. The film’s distributor, A24, described the movie as “an intimate portrait of an enigmatic felon” that became “a mind-bending three-year journey into the abyss.” It is set to be released on Oct. 16.
Mr. Evans declined to comment.
Ms. Holmes has also become active on social media while in prison, posting about artificial intelligence, longevity and the health care system, and making the unfounded claim that Theranos’s technology worked. Her account describes her posts as “mostly my words, posted by others.”
John Carreyrou contributed reporting.